Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Inflammatory Breast Cancer

ABSTRACT: Gene expression profiles were established for Inflammatory breast cancer samples from patients treated at the Institut Paoli-Calmettes.

ORGANISM(S): Homo sapiens

SUBMITTER: Pascal FINETTI

PROVIDER: E-MTAB-1547 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Cholesterol pathway influences tumor molecular differentiation and impacts survival in colon cancer patients

Project description:Part of a meta-analysis, DNA microarrays were used to define the transcriptional profiles of tumor samples of 50 colon cancer samples at Institut Paoli-Calmettes.

2022-09-01 | E-MTAB-11754 | biostudies-arrayexpress

High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes

Project description:Inflammatory breast cancer (IBC) is an aggressive form of BC poorly defined at the molecular level. We compared the molecular portraits of 63 IBC and 134 non-IBC (nIBC) clinical samples. Genomic imbalances of 49 IBCs and 124 nIBCs were determined using high-resolution array-comparative genomic hybridization, and mRNA expression profiles of 197 samples using whole-genome microarrays. Genomic profiles of IBCs were as heterogeneous as those of nIBCs, and globally relatively close. However, IBCs showed more frequent “complex” patterns and a higher percentage of genes with CNAs per sample. The number of altered regions was similar in both types, although some regions were altered more frequently and/or with higher amplitude in IBCs. Many genes were similarly altered in both types; however, more genes displayed recurrent amplifications in IBCs. Pre-treatment tumor tissues were collected from 197 patients with invasive adenocarcinomas. Patients underwent surgical biopsies or initial surgery at the Institut Paoli-Calmettes (IPC, Marseille, France) between 1987 and 2007. Each patient gave written informed consent and the study was approved by the IPC “Comité d’Orientation Stratégique”. Tumor samples were macrodissected and frozen in liquid nitrogen within 30 minutes of removal. Before RNA extraction, tumor sections were reviewed by two pathologists and contained more than 60% of tumor cells. Gene expression data of the 197 BCs were quantified using whole-genome DNA microarrays (HG-U133 Plus 2.0, Affymetrix).

2011-03-01 | E-GEOD-23720 | biostudies-arrayexpress

Institut Paoli Calmettes Colorectal Cancer Database

Project description:Database of Institut Paoli-Calmettes patients diagnosed with colorectal cancer

| 2222603 | ecrin-mdr-crc

Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling

Project description:To better understand Luminal B subtype we studied in 188 breast cancers of various molecular subtypes, DNA copy number aberrations (CNAs), DNA promoter methylation and gene expression profiles. Please note mRNA expression data already submitted for study: E-GEOD-21653.

2014-01-01 | E-MTAB-1861 | biostudies-arrayexpress

Gene expression profiling in myeloproliferative neoplasms

Project description:Gene expression profiles were established for 50 MPNs samples. RNA extracted from 2 healthy people was used as control. All MPNs were screened for JAK2V617F mutation as part of routine diagnostic practice.

2011-12-31 | E-MTAB-510 | biostudies-arrayexpress

Gene expressionprofiling of breast cell lines

Project description:We performed gene expression profiling of 31 breast cell lines (BCL) using whole-genome DNA microarrays (Affymetrix U133+2.0) to assessed a better molecular characterization of breast cell lines in order to help discover of new markers to apply to tumour samples.

2013-06-10 | E-MTAB-1693 | biostudies-arrayexpress

Prospective high-throughput genome profiling by comparative genomic hybridization (CGH) in advanced cancers.

Project description:We conducted a prospective monocenter clinical trial called PERMED01 to evaluate the number patients with locally advanced or metastatic cancer for whom identification of molecular alterations in tumor samples could lead to the delivery of a targeted therapy. Patients accessible to tumor biopsy were prospectively enrolled at the Paoli-Calmettes Institute in the PERMED01 study (ClinicalTrials.gov, NCT02342158). Genomic profiling of frozen tissue was established by whole-genome array comparative genomic hybridization (aCGH)

2021-03-01 | E-MTAB-9998 | biostudies-arrayexpress

breast cancer cell lines ALDH+/-

Project description:Self-renewal and differentiation are two epigenetic programs that regulate pluripotency of stem cells. During oncogenesis, dysregulation of these two programs leads to the development of cancer stem cells (CSCs). Here, we used a pan genomic promoter microarray to determine the DNA methylation portrait of breast cancer stem cells (bCSC) compared to non-bCSC

2015-01-01 | E-MTAB-2236 | biostudies-arrayexpress

Genome profiling of pancreatic adenocarcinoma

Project description:Pancreatic adenocarcinoma is one of the most aggressive human cancers and displays many different chromosomal abnormalities and mutations. By using 244K high-resolution array-comparative genomic hybridization (aCGH) we studied the genome alterations of 39 fine-needle aspirations from pancreatic adenocarcinoma and 9 human adenocarcinoma pancreatic cell lines.

2011-12-31 | E-MTAB-570 | biostudies-arrayexpress

Gene expression profiling of solitary fibrous tumors

Project description:Sixteen pre-treatment samples of pathologically confirmed solitary fibrous tumors (SFT) were available for RNA profiling. They were collected from 16 patients who underwent initial surgery and/or diagnostic biopsy. Samples were macrodissected by pathologists, and frozen within 30 min of removal in liquid nitrogen in our biobank (Biobank authorization number 2008/70, APHM). All profiled specimens contained more than 70% tumor cells. Each patient gave written informed consent for molecular analysis, and the study was approved by our institutional ethics committee. Total RNA was extracted from frozen samples by using the All-In-One Norgen Biotek kit (Thorold, Canada) and integrity was controlled by Agilent analysis (Bioanalyzer, Palo Alto, CA). Gene expression profiling was done with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays with labeling kit and protocol from manufacturer.

2013-11-12 | E-MTAB-1361 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data